Condition
Cancer Genetics
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Insights
Highlights
Success Rate
75% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 87/100
Termination Rate
25.0%
1 terminated out of 4 trials
Success Rate
75.0%
-11.5% vs benchmark
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
0%
0 of 3 completed with results
Key Signals
75% success
Data Visualizations
Phase Distribution
1Total
Not Applicable (1)
Trial Status
Completed3
Terminated1
Trial Success Rate
75.0%
Benchmark: 86.5%
Based on 3 completed trials
Clinical Trials (4)
Showing 4 of 4 trials
NCT01374685Terminated
Family Communication of Hereditary Breast and Ovarian Cancer Risk Among African Americans
NCT00339508Completed
Exploratory Data Analysis for Disease Pedigrees and Cancer Genetics
NCT01866865CompletedPrimary
Adaptation to Living With a BRCA1/2 Mutation
NCT01562431Not ApplicableCompleted
The Signal-Trial: Evaluation of a Screening Tool for Psychosocial Problems in Cancer Genetics
Showing all 4 trials